Peter P. Lee

15.2k total citations · 2 hit papers
209 papers, 10.6k citations indexed

About

Peter P. Lee is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Peter P. Lee has authored 209 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Immunology, 82 papers in Oncology and 51 papers in Molecular Biology. Recurrent topics in Peter P. Lee's work include Immunotherapy and Immune Responses (54 papers), Cancer Immunotherapy and Biomarkers (48 papers) and T-cell and B-cell Immunology (43 papers). Peter P. Lee is often cited by papers focused on Immunotherapy and Immune Responses (54 papers), Cancer Immunotherapy and Biomarkers (48 papers) and T-cell and B-cell Immunology (43 papers). Peter P. Lee collaborates with scholars based in United States, Canada and South Korea. Peter P. Lee's co-authors include Mark M. Davis, Jeffrey S. Weber, Philip D. Greenberg, Cassian Yee, Peter A. Savage, Tor B. Stuge, Denise Johnson, Susan Holmes, Mario Roederer and Jeffrey J. Molldrem and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Peter P. Lee

207 papers receiving 10.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1999 919 citations Peter P. Lee, Jeffrey S. Weber et al. profile →
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia

2000 531 citations Peter P. Lee et al. profile →

Peers

Countries citing papers authored by Peter P. Lee

Since Specialization

Citations

This map shows the geographic impact of Peter P. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter P. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter P. Lee more than expected).

Fields of papers citing papers by Peter P. Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter P. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter P. Lee. The network helps show where Peter P. Lee may publish in the future.

Co-authorship network of co-authors of Peter P. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Peter P. Lee. A scholar is included among the top collaborators of Peter P. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter P. Lee. Peter P. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PD-L1-expressing tumor-associated macrophages are immunostimulatory and associate with good clinical outcome in human breast cancer 2024 ·Cell Reports Medicine ·Lei Wang, Weihua Guo, (unknown), Jiangnan Yu, Jiayi Tan, Diana L. Simons, (unknown), Xinyu Liu, Qian Zhou, Yi-Zi Zheng, (unknown), John H. Yim, James Waisman, Peter P. Lee	46
2	A phase I/II trial of palbociclib, pembrolizumab, and endocrine therapy for patients with HR+/HER2- locally advanced or metastatic breast cancer (MBC): Clinical outcomes and stool microbial profiling. 2024 ·Journal of Clinical Oncology ·(unknown), Colt A. Egelston, Susan E. Yost, Paul Frankel, (unknown), Christopher Ruel, Daniel Schmolze, Peter P. Lee, Christina Yeon, Yuan Yuan, James Waisman, Sumanta K. Pal, Joanne Mortimer	1
3	Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer 2024 ·Cancer Immunology Research ·Colt A. Egelston, Weihua Guo, Diana L. Simons, Jian Ye, Christian Avalos, Shawn T. Solomon, (unknown), Michael S. Nelson, Jiayi Tan, (unknown), (unknown), Daniel Schmolze, Lusine Tumyan, James Waisman, Peter P. Lee	2
4	Tumor draining lymph nodes connected to cold triple-negative breast cancers are characterized by Th2-associated microenvironment 2024 ·Nature Communications ·Weihua Guo, Jiayi Tan, Lei Wang, Colt A. Egelston, Diana L. Simons, (unknown), (unknown), Lu Wang, Shawn T. Solomon, James Waisman, Christina Wei, Caroline Hoffmann, Joo Y. Song, Daniel Schmolze, Peter P. Lee	5
5	Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti–PD-L1 and lenalidomide in cutaneous T cell lymphoma 2023 ·JCI Insight ·(unknown), Xiwei Wu, Hanjun Qin, Yate‐Ching Yuan, Daniel Schmolze, (unknown), Jasmine M. Zain, Lilach Moyal, Emmilia Hodak, James F. Sanchez, Peter P. Lee, Mingye Feng, Steven T. Rosen, Christiane Querfeld	12
6	Trajectories of Quality of Life After Pelvic Exenteration: A Latent Class Growth Analysis 2023 ·Diseases of the Colon & Rectum ·Daniel Steffens, (unknown), Michael J. Solomon, Peter P. Lee, Kirk K. S. Austin, Christopher M. Byrne, Sascha Karunaratne, Cherry Koh	2
7	Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor–positive breast cancer 2022 ·JCI Insight ·Colt A. Egelston, Weihua Guo, Jiayi Tan, Christian Avalos, Diana L. Simons, (unknown), Yinghui Huang, Michael S. Nelson, (unknown), Daniel Schmolze, John H. Yim, Laura Kruper, Laleh G. Melstrom, Kim Margolin, Joanne Mortimer, Yuan Yuan, James Waisman, Peter P. Lee	25
8	PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages 2022 ·Journal for ImmunoTherapy of Cancer ·Yukiko Yamaguchi, (unknown), (unknown), (unknown), Raymond T. Ng, Neena A. Leggett, Vanessa D. Jönsson, Jelani C. Zarif, Peter P. Lee, Xiuli Wang, Catalina Martínez, Tanya B. Dorff, Stephen J. Forman, Saul J. Priceman	74
9	Dissecting Response to Cancer Immunotherapy by Applying Bayesian Network Analysis to Flow Cytometry Data 2021 ·International Journal of Molecular Sciences ·Andréi S. Rodin, Grigoriy Gogoshin, (unknown), Lei Wang, Colt A. Egelston, Russell C. Rockne, Joseph Chao, Peter P. Lee	11
10	A Phase 2 Trial Combining Pembrolizumab and Palliative Radiation Therapy in Gastroesophageal Cancer to Augment Abscopal Immune Responses 2021 ·Advances in Radiation Oncology ·Joseph Chao, Ting-Fang He, Massimo D’Apuzzo, Yi‐Jen Chen, Paul Frankel, (unknown), Helen Chen, Shawn T. Solomon, Samuel J. Klempner, Marwan Fakih, Peter P. Lee	7
11	Spatial distribution of B cells and lymphocyte clusters as a predictor of triple-negative breast cancer outcome 2021 ·npj Breast Cancer ·(unknown), Ting-Fang He, Shawn T. Solomon, (unknown), (unknown), (unknown), Travis Y. Tu, Daniel Schmolze, Yuan Yuan, Susan E. Yost, Xuefei Li, Herbert Levine, Gurinder S. Atwal, Peter P. Lee, Clare C. Yu	28
12	Concepts and Applications of Information Theory to Immuno-Oncology 2021 ·Trends in cancer ·Aleksandra Karolak, Sergio Branciamore, Jeannine S. McCune, Peter P. Lee, Andréi S. Rodin, Russell C. Rockne	10
13	Building a rapid autopsy program – a step-by-step logistics guide 2020 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Peter P. Lee, James Waisman	6
14	Selective ablation of cancer cells with low intensity pulsed ultrasound 2020 ·Applied Physics Letters ·David R. Mittelstein, Jian Ye, (unknown), (unknown), (unknown), M. Houman Fekrazad, M. Ortíz, Peter P. Lee, Mikhail G. Shapiro, Morteza Gharib	59
15	Connecting blood and intratumoral Treg cell activity in predicting future relapse in breast cancer 2019 ·Nature Immunology ·Lei Wang, Diana L. Simons, Xuyang Lu, Travis Y. Tu, Shawn T. Solomon, Ruo‐Qian Wang, (unknown), Christian Avalos, Daniel Schmolze, John H. Yim, James Waisman, Peter P. Lee	125
16	Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression 2018 ·Nature Communications ·Colt A. Egelston, Christian Avalos, Travis Y. Tu, Diana L. Simons, (unknown), Jae Yoon Jung, Laleh G. Melstrom, Kim Margolin, John H. Yim, Laura Kruper, Joanne Mortimer, Peter P. Lee	97
17	On the mechanism of long-range orientational order of fibroblasts 2017 ·Proceedings of the National Academy of Sciences ·Xuefei Li, (unknown), Ting-Fang He, Peter P. Lee, Oleg A. Igoshin, Herbert Levine	49
18	IL6 Signaling in Peripheral Blood T Cells Predicts Clinical Outcome in Breast Cancer 2016 ·Cancer Research ·Lei Wang, Andrea K. Miyahira, Diana L. Simons, Xuyang Lu, Andrew Y. Chang, Carrie Wang, Maria Suni, Vernon C. Maino, Frederick M. Dirbas, John H. Yim, James Waisman, Peter P. Lee	37
19	Memory T cells have gene expression patterns intermediate between naïve and effector 2005 ·Proceedings of the National Academy of Sciences ·Susan Holmes, (unknown), Tong Xu, Peter P. Lee	56
20	Immunologic Monitoring of Cancer Vaccine Therapy: Results of a Workshop Sponsored by the Society for Biological Therapy 2002 ·Journal of Immunotherapy ·Ulrich Keilholz, Jeffrey S. Weber, James H. Finke, Dmitry I. Gabrilovich, W. Martin Kast, Mary L. Disis, John M. Kirkwood, Carmen Scheibenbogen, Jeff Schlom, Vernon C. Maino, H. Kim Lyerly, Peter P. Lee, Walter J. Storkus, (unknown), Alexandra S. Worobec, Michael B. Atkins	235

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact